Infinity Pharmaceuticals Inc (NASDAQ:INFI)
| 1.19 Delayed Data As of Sep 30 |  -0.01 / -0.83%Today’s Change | 0.46 Today|||52-Week Range 3.42 | -47.11% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Year Trend | |||||
|---|---|---|---|---|---|---|
2015 | 2016 | 2017 | 2018 | |||
| Revenue and Income | Net Revenues | 109.1M | 18.7M | 6.0M | 22.1M | |
| Depreciation And Amortization | 2.3M | 3.4M | 1.7M | 191.0K | ||
| Operating Expenses | Gross Income | -- | -- | -- | -- | -- |
| General Expenses | 233.9M | 139.9M | 40.7M | 33.9M | ||
| Research And Development | 199.1M | 106.9M | 20.8M | 19.8M | ||
| Total Operating Expenses | 236.2M | 143.3M | 42.4M | 34.1M | ||
| Non-Operating Expenses | Operating Income | -127.1M | -124.6M | -36.4M | -11.9M | |
| Extraordinary Credit | 0.00 | 114.9M | 0.00 | 0.00 | ||
| Extraordinary Charge | 0.00 | -21.2M | -6.9M | 0.00 | ||
| Interest Expense On Debt | 1.4M | 1.2M | 1.0M | 93.0K | ||
| Income Taxes, Minority Interest and Extra Items | Pre-Tax Income | -128.0M | -30.1M | -42.6M | -11.3M | |
| Income Taxes | -335.0K | 0.00 | -720.0K | 0.00 | ||
| Net Income | -128.4M | -30.1M | -41.8M | -11.3M | ||
| Shares To Calculate EPS | Shares To Calculate EPS | 49.1M | 49.6M | 50.6M | 55.4M | |
| Shares To Calculate EPS Diluted | 49.1M | 49.6M | 50.6M | 55.4M | ||
| Earnings Per Share | EPS | -$2.62 | -$0.61 | -$0.83 | -$0.20 | |
| EPS Diluted | -$2.62 | -$0.61 | -$0.83 | -$0.20 | ||
